Segment Information (Tables)

9 Months Ended

Sep. 30, 2017



	Operating Results
Three Months Ended September 30, 2017	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	6,987		$	1,696		$	701		$	527		$	989		$	13		$	10,913		$	(37	)	$	10,876
Universal life and investment-type product policy fees	247			458			229			109			349			—			1,392			36			1,428
Net investment income	1,602			762			299			77			1,390			26			4,156			139			4,295
Other revenues	197			11			7			(2		)	37			65			315			(14		)	301
Net investment gains (losses)	—			—			—			—			—			—			—			(606		)	(606		)
Net derivative gains (losses)	—			—			—			—			—			—			—			(190		)	(190		)
Total revenues	9,033			2,927			1,236			711			2,765			104			16,776			(672		)	16,104
Expenses
Policyholder benefits and claims and policyholder dividends	6,904			1,223			640			282			1,661			7			10,717			230			10,947
Interest credited to policyholder account balances	376			349			99			26			255			—			1,105			233			1,338
Capitalization of DAC	(126		)	(420		)	(94		)	(109		)	(14		)	(2		)	(765		)	4			(761		)
Amortization of DAC and VOBA	118			424			—			78			(70		)	3			553			73			626
Amortization of negative VOBA	—			(24		)	(1		)	(5		)	—			—			(30		)	(2		)	(32		)
Interest expense on debt	2			—			1			—			2			279			284			—			284
Other expenses	933			905			377			347			322			237			3,121			80			3,201
Total expenses	8,207			2,457			1,022			619			2,156			524			14,985			618			15,603
Provision for income tax expense (benefit)	280			156			51			21			199			(90		)	617			(1,009		)	(392		)
Operating earnings	$	546		$	314		$	163		$	71		$	410		$	(330	)	1,174
Adjustments to:
Total revenues																			(672		)
Total expenses																			(618		)
Provision for income tax (expense) benefit																			1,009
Income (loss) from continuing operations, net of income tax																			$	893					$	893



	Operating Results
Three Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	5,936		$	1,822		$	653		$	500		$	1,093		$	41		$	10,045		$	(206	)	$	9,839
Universal life and investment-type product policy fees	245			394			227			104			357			—			1,327			14			1,341
Net investment income	1,590			707			311			81			1,537			53			4,279			330			4,609
Other revenues	192			12			11			17			105			22			359			(3		)	356
Net investment gains (losses)	—			—			—			—			—			—			—			231			231
Net derivative gains (losses)	—			—			—			—			—			—			—			(543		)	(543		)
Total revenues	7,963			2,935			1,202			702			3,092			116			16,010			(177		)	15,833
Expenses
Policyholder benefits and claims and policyholder dividends	5,894			1,363			681			257			1,853			31			10,079			(165		)	9,914
Interest credited to policyholder account balances	322			331			85			28			261			(1		)	1,026			518			1,544
Capitalization of DAC	(124		)	(440		)	(83		)	(103		)	(44		)	1			(793		)	23			(770		)
Amortization of DAC and VOBA	117			331			(2		)	106			219			1			772			(112		)	660
Amortization of negative VOBA	—			(46		)	(1		)	(3		)	—			—			(50		)	(5		)	(55		)
Interest expense on debt	2			—			1			—			15			275			293			(13		)	280
Other expenses	912			930			335			332			401			85			2,995			106			3,101
Total expenses	7,123			2,469			1,016			617			2,705			392			14,322			352			14,674
Provision for income tax expense (benefit)	288			142			53			11			121			(288		)	327			(192		)	135
Operating earnings	$	552		$	324		$	133		$	74		$	266		$	12		1,361
Adjustments to:
Total revenues																			(177		)
Total expenses																			(352		)
Provision for income tax (expense) benefit																			192
Income (loss) from continuing operations, net of income tax																			$	1,024					$	1,024



	Operating Results
Nine Months Ended September 30, 2017	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	18,049		$	5,063		$	1,993		$	1,534		$	3,070		$	59		$	29,768		$	(347	)	$	29,421
Universal life and investment-type product policy fees	763			1,199			764			296			1,056			—			4,078			74			4,152
Net investment income	4,789			2,193			891			229			4,232			107			12,441			468			12,909
Other revenues	600			32			24			43			170			185			1,054			(119		)	935
Net investment gains (losses)	—			—			—			—			—			—			—			(439		)	(439		)
Net derivative gains (losses)	—			—			—			—			—			—			—			(663		)	(663		)
Total revenues	24,201			8,487			3,672			2,102			8,528			351			47,341			(1,026		)	46,315
Expenses
Policyholder benefits and claims and policyholder dividends	18,017			3,785			1,869			821			5,117			33			29,642			206			29,848
Interest credited to policyholder account balances	1,086			1,003			275			75			767			1			3,207			874			4,081
Capitalization of DAC	(342		)	(1,268		)	(264		)	(301		)	(71		)	(6		)	(2,252		)	34			(2,218		)
Amortization of DAC and VOBA	346			1,005			146			260			143			5			1,905			40			1,945
Amortization of negative VOBA	—			(91		)	(1		)	(13		)	—			—			(105		)	(8		)	(113		)
Interest expense on debt	8			—			4			—			22			833			867			(16		)	851
Other expenses	2,756			2,675			1,060			995			1,032			649			9,167			272			9,439
Total expenses	21,871			7,109			3,089			1,837			7,010			1,515			42,431			1,402			43,833
Provision for income tax expense (benefit)	782			459			123			47			488			(642		)	1,257			(1,405		)	(148		)
Operating earnings	$	1,548		$	919		$	460		$	218		$	1,030		$	(522	)	3,653
Adjustments to:
Total revenues																			(1,026		)
Total expenses																			(1,402		)
Provision for income tax (expense) benefit																			1,405
Income (loss) from continuing operations, net of income tax																			$	2,630					$	2,630



	Operating Results
Nine Months Ended September 30, 2016	U.S.			Asia			Latin America			EMEA			MetLife Holdings			Corporate & Other			Total			Adjustments			Total Consolidated
	(In millions)
Revenues
Premiums	$	16,127		$	5,161		$	1,885		$	1,519		$	3,312		$	50		$	28,054		$	(98	)	$	27,956
Universal life and investment-type product policy fees	743			1,114			764			294			1,073			2			3,990			137			4,127
Net investment income	4,615			2,003			809			244			4,489			141			12,301			226			12,527
Other revenues	589			45			26			56			512			70			1,298			11			1,309
Net investment gains (losses)	—			—			—			—			—			—			—			598			598
Net derivative gains (losses)	—			—			—			—			—			—			—			1,438			1,438
Total revenues	22,074			8,323			3,484			2,113			9,386			263			45,643			2,312			47,955
Expenses
Policyholder benefits and claims and policyholder dividends	16,210			3,923			1,814			801			5,603			23			28,374			(56		)	28,318
Interest credited to policyholder account balances	967			974			249			87			780			5			3,062			757			3,819
Capitalization of DAC	(356		)	(1,251		)	(236		)	(310		)	(240		)	(7		)	(2,400		)	(22		)	(2,422		)
Amortization of DAC and VOBA	353			921			127			311			636			7			2,355			(303		)	2,052
Amortization of negative VOBA	—			(167		)	(1		)	(10		)	—			—			(178		)	(43		)	(221		)
Interest expense on debt	7			—			1			—			43			862			913			(38		)	875
Other expenses	2,772			2,658			968			1,001			1,861			401			9,661			351			10,012
Total expenses	19,953			7,058			2,922			1,880			8,683			1,291			41,787			646			42,433
Provision for income tax expense (benefit)	720			377			141			32			203			(658		)	815			438			1,253
Operating earnings	$	1,401		$	888		$	421		$	201		$	500		$	(370	)	3,041
Adjustments to:
Total revenues																			2,312
Total expenses																			(646		)
Provision for income tax (expense) benefit																			(438		)
Income (loss) from continuing operations, net of income tax																			$	4,269					$	4,269

The following table presents total assets with respect to the Company’s segments, as well as Corporate & Other, at:

__________________


(1)	Includes assets of disposed subsidiary of $216,983 million at December 31, 2016.